Results of Quinacrine Administration to Patients with Creutzfeldt-Jakob Disease

Publisher： Karger

E-ISSN： 1421-9824|17|3|158-163

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.17, Iss.3, 2004-03, pp. : 158-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Proteomic Analysis of the Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 1, 2006-10 ,pp. : 22-28

Karger

Access to resources Recommend Favorite

Chronological Changes in MRI and CSF Biochemical Markers in Creutzfeldt-Jakob Disease Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 6, 2007-03 ,pp. : 372-381

Karger

Access to resources Recommend Favorite

How Is Creutzfeldt-Jakob Disease Acquired?

By  

Neuroepidemiology, Vol. 19, Iss. 2, 2000-02 ,pp. : 55-61

Karger

Access to resources Recommend Favorite

Creutzfeldt-Jakob Disease in Ireland: Epidemiological Aspects 1980–2002

By  

European Neurology, Vol. 51, Iss. 3, 2004-05 ,pp. : 132-137

Karger

Access to resources Recommend Favorite

Levetiracetam Control of Myoclonus in a Patient with Creutzfeldt-Jakob Disease

By  

European Neurology, Vol. 49, Iss. 3, 2003-03 ,pp. : 189-190

Karger

Access to resources Recommend Favorite